Display options
Share it on

J Pathog. 2016;2016:7163615. doi: 10.1155/2016/7163615. Epub 2016 Jan 26.

Prevalence of Methicillin Resistant Staphylococcal Bioaerosols in and around Residential Houses in an Urban Area in Central India.

Journal of pathogens

P Kumar, A K Goel

Affiliations

  1. Biotechnology Division, Defence Research & Development Establishment, Gwalior 474002, India; Department of Microbiology, National Centre for Disease Control (NCDC), Delhi 110054, India.
  2. Biotechnology Division, Defence Research & Development Establishment, Gwalior 474002, India.

PMID: 26925268 PMCID: PMC4746351 DOI: 10.1155/2016/7163615

Abstract

Methicillin resistant staphylococci (MRS) commonly found in clinical samples or associated environment pose a major health challenge globally. The carriage rate of MRS in human population is high, especially in India but research on airborne distribution of MRS is scanty. The present study aimed to evaluate the prevalence of MRS in indoor and outdoor environment of residential houses. Air samples were collected using impactor air sampler. The total counts of viable bacteria, staphylococci, and MRS along with the particles of various sizes were determined from indoor and outdoor environment of 14 residential houses. MRS bacteria were identified as methicillin resistant S. aureus (MRSA) or coagulase negative staphylococci (CNS) employing biochemical and PCR assays. The average concentration of MRS inside and outside of the houses was 5.9% and 4.6% of the total bacteria, respectively. The maximum correlation of total indoor and outdoor bacteria with particulate matter was 10 μm (r = 0.74) and 5 μm (r = 0.84), respectively. Statistically, significant positive correlation of staphylococci and MRS was found with particles of 10-25 μm inside the houses. Molecular surveillance, antibiotic stewardship programme, and infection control policies can help to manage increasing MRS burden in developing countries.

References

  1. J Hosp Infect. 2002 Jan;50(1):30-5 - PubMed
  2. J Formos Med Assoc. 2015 Jul;114(7):639-46 - PubMed
  3. Future Microbiol. 2007 Oct;2(5):457-9 - PubMed
  4. J Infect Dev Ctries. 2009 Aug 30;3(7):554-60 - PubMed
  5. Infect Control Hosp Epidemiol. 1999 Jun;20(6):408-11 - PubMed
  6. Scand J Infect Dis. 2000;32(6):587-95 - PubMed
  7. J Expo Anal Environ Epidemiol. 2000 Nov-Dec;10(6 Pt 1):518-32 - PubMed
  8. Curr Mol Med. 2009 Mar;9(2):100-15 - PubMed
  9. Br Med J. 1966 Feb 5;1(5483):319-22 - PubMed
  10. J Hosp Infect. 1998 Jun;39(2):127-33 - PubMed
  11. Clin Infect Dis. 2005 Jun 15;40(12):1785-91 - PubMed
  12. JAMA. 2007 Oct 17;298(15):1763-71 - PubMed
  13. J Hyg (Lond). 1978 Dec;81(3):471-9 - PubMed
  14. Indoor Air. 2005;15 Suppl 9:48-57 - PubMed
  15. Mol Microbiol. 2007 Apr;64(1):83-93 - PubMed
  16. J Hyg (Lond). 1959 Sep;57:299-308 - PubMed
  17. Appl Environ Microbiol. 1982 Jul;44(1):179-83 - PubMed
  18. Health Lab Sci. 1975 Jan;12(1):47-51 - PubMed
  19. Appl Environ Microbiol. 1983 Mar;45(3):919-34 - PubMed
  20. Lab Invest. 2007 Jan;87(1):3-9 - PubMed
  21. Ann Fam Med. 2006 Mar-Apr;4(2):132-7 - PubMed
  22. Indian J Med Res. 2009 Dec;130(6):742-8 - PubMed
  23. J Clin Microbiol. 2008 Sep;46(9):2837-41 - PubMed
  24. Jpn J Infect Dis. 2003 Apr;56(2):54-6 - PubMed
  25. Infect Control Hosp Epidemiol. 2007 Sep;28(9):1047-53 - PubMed
  26. Appl Environ Microbiol. 1976 Oct;32(4):633-4 - PubMed
  27. J Clin Microbiol. 2001 Sep;39(9):3332-8 - PubMed
  28. Ann N Y Acad Sci. 1965 Jul 23;128(1):92-111 - PubMed
  29. Indian J Med Microbiol. 2008 Apr-Jun;26(2):105-7 - PubMed
  30. Indian J Med Res. 2008 Aug;128(2):165-71 - PubMed
  31. J Clin Microbiol. 1994 Jul;32(7):1768-72 - PubMed

Publication Types